Back to User profile » Dr Ren-Chin Wu

Papers published by Dr Ren-Chin Wu:

Original Research

Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival

Chiang K, Huang S, Wu RC, Huang SC, Yeh T, Chen M, Hsu JT, Chen L, Kuo SF, Chueh H, Juang H, Hung S, Yeh C, Pang JS

Cancer Management and Research 2019, 11:1893-1905

Published Date: 28 February 2019

Original Research

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy

Yeh CN, Wu RC, Cheng CT, Tsai CY, Chang YR, Yeh TS, Wu TH, Lee WC, Chiang KC

Cancer Management and Research 2018, 10:6049-6059

Published Date: 21 November 2018

Original Research

Pancolitis associated with higher mortality risk of cytomegalovirus colitis in patients without inflammatory bowel disease

Le PH, Kuo CJ, Wu RC, Hsu JT, Su MY, Lin CJ, Chiu CT

Therapeutics and Clinical Risk Management 2018, 14:1445-1451

Published Date: 20 August 2018

Original Research

Clinical characteristics of cytomegalovirus colitis: a 15-year experience from a tertiary reference center

Le PH, Lin WR, Kuo CJ, Wu RC, Hsu JT, Su MY, Lin CJ, Chiu CT

Therapeutics and Clinical Risk Management 2017, 13:1585-1593

Published Date: 15 December 2017